The global Non-invasive ICP Device market size is predicted to grow from US$ 562 million in 2025 to US$ 935 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.

In 2025, global production of non-invasive ICP devices reached 82,000 units, with an average selling price of USD 7,000 per unit, total production capacity of 100,000 units, and an average gross margin of 60%.

A non-invasive ICP device is a medical instrument designed to assess and monitor intracranial pressure without penetrating the skull or brain tissue. These devices typically estimate ICP using technologies such as ultrasound, physiological signal modeling, or ocular and cerebral blood flow?related parameters. They help clinicians identify intracranial hypertension risk while avoiding complications associated with invasive monitoring, and are used in neurocritical care, emergency medicine, and selected pre-hospital settings.

The upstream of non-invasive ICP devices mainly includes suppliers of ultrasound transducers, pressure and physiological signal sensors, electronic components, algorithm software, and industrial design services. The midstream consists of medical device manufacturers responsible for R&D, system integration, clinical validation, and regulatory approval. Downstream customers primarily include hospital ICUs, neurosurgery departments, emergency departments, and selected emergency medical and patient transport services.

United States market for Non-invasive ICP Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Non-invasive ICP Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Non-invasive ICP Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Non-invasive ICP Device players cover Integra LifeSciences, Medtronic, Sophysa Ltd, Spiegelberg, Raumedic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

Infinity Market Research newest research report, the ?Non-invasive ICP Device Industry Forecast? looks at past sales and reviews total world Non-invasive ICP Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive ICP Device sales for 2026 through 2032. With Non-invasive ICP Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive ICP Device industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive ICP Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive ICP Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-invasive ICP Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive ICP Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive ICP Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive ICP Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Sound Signal Monitoring
    Blood Flow Signal Monitoring
    Segmentation by Monitoring Principle:
    Transcranial Doppler (TCD)-based
    Optic Nerve Sheath Diameter (ONSD)-based
    Segmentation by Signal Acquisition Method:
    Ultrasound-based
    Physiological Signal Modeling-based
    Segmentation by Device Form Factor:
    Portable
    Bedside

Segmentation by Application:

    Traumatic Brain Injury
    Cerebral Hemorrhage
    Meningitis
    Subarachnoid Hemorrhage
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Integra LifeSciences
    Medtronic
    Sophysa Ltd
    Spiegelberg
    Raumedic
    HeadSense Medical
    Vittamed

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-invasive ICP Device market?
What factors are driving Non-invasive ICP Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive ICP Device market opportunities vary by end market size?
How does Non-invasive ICP Device break out by Type, by Application?